why choose us

First received: December 16, 2022

Clinical Trial: Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Blood Loss, Surgical
Intrapartum Hemorrhage

Study Type: Interventional


Official Title: Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Intraoperative Blood Loss in Women Undergoing Planned Cesarean Section

Brief Summary: The aim of this clinical trial is to test if carbetocin is as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section.The main question it aims to answer is:* Is carbetocin as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section?Researchers will compare 2 groups:women receiving Oxytocin plus Misoprostol;women receiving Carbetocin as regards:estimated blood loss

Read more